News-Medical.Net October 17, 2024
University of Zurich (UZH)

Researchers at the University of Zurich (UZH) have used artificial intelligence (AI) to help identify antibiotic-resistant bacteria. The team led by Adrian Egli, UZH professor at the Institute of Medical Microbiology, is the first to investigate how GPT-4, a powerful AI model developed by OpenAI, can be used to analyze antibiotic resistance.

The researchers used AI to interpret a common laboratory test known as the Kirby-Bauer disk diffusion test, which helps doctors to determine which antibiotics can or can’t fight a particular bacterial infection. Based on GPT-4, the scientists created the “EUCAST-GPT-expert”, which follows strict EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines for interpreting antimicrobial resistance mechanisms. By incorporating the latest data and expert rules, the system was tested...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
Google digs deeper into healthcare AI: 5 notes
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
How AI Has And Will Continue To Transform Healthcare
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024
Building AI trust: The key role of explainability

Share This Article